REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glukanmed Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Glukanmed Sp. z o.o. Profile Updated: May 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Glukanmed Sp. z o.o. is a company based in Poland, with its head office in Lodz. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was first established on July 31, 2018. From the latest financial highlights, Glukanmed Sp. z o.o. reported a net sales revenue increase of 62.3% in 2023. Its total assets decreased by 71.56% over the same period.

Headquarters
Ul. Aleja T. Kosciuszki 80/82/301
Lodz; Lodzkie; Postal Code: 90-437

Contact Details: Purchase the Glukanmed Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Glukanmed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Glukanmed Sp. z o.o. report to view the information.
Incorporation Date:
July 31, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
28%
Purchase this report to view the information.
28%
Purchase this report to view the information.
24%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Glukanmed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
62.3%▲
Total operating revenue
-76.23%▼
Operating profit (EBIT)
N/A
EBITDA
-82.67%▼
Net Profit (Loss) for the Period
N/A
Total assets
-71.56%▼
Total equity
-82.14%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo